Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2015, Article ID 517472, 7 pages
http://dx.doi.org/10.1155/2015/517472
Clinical Study

Urinary Angiotensinogen Could Be a Prognostic Marker of Renoprotective Effects of Alogliptin in Patients with Type 2 Diabetes

1Kagawa University School of Medicine, Kagawa 761-0793, Japan
2Jichi Medical University School of Medicine, Tochigi, Japan
3Tulane University Health Sciences Center, New Orleans, LA, USA
4Miyazaki University School of Medicine, Miyazaki, Japan

Received 11 November 2014; Revised 1 February 2015; Accepted 9 February 2015

Academic Editor: Bagher Larijani

Copyright © 2015 Tomoko Mizushige et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Tomoko Mizushige, Hiroyuki Kobori, Yoko Nishijima, et al., “Urinary Angiotensinogen Could Be a Prognostic Marker of Renoprotective Effects of Alogliptin in Patients with Type 2 Diabetes,” Journal of Diabetes Research, vol. 2015, Article ID 517472, 7 pages, 2015. https://doi.org/10.1155/2015/517472.